Skip to Content

ERYMAX 250MG GASTRO-RESISTANT HARD CAPSULE

PDF options:  View Fullscreen   Download PDF

PDF Transcript

Print Specification Box
Client

revised in March 2012.

Barcode
Varnish Type
Braille
Fold Dimensions (PIL Only)
Perforation (PIL Only)
Roll Width (Label Only)
Sequential Numbering (Label Only)

Colours
0111/17
PX309/12

PX309/12

Keyline Reference

N/A

Pharmacode
Varnish Free Area

30912
N/A

Fold Configuration (PIL Only)

Erymax

N/A
N/A

Leading Edge (Label Only)

N/A
N/A

N/A
N/A

Material

Ridings Point,
Whistler Drive,
Castleford,
West Yorkshire,
WF10 5HX,
UK

Part No.

34 X 148MM
N/A

Dimensions

Max OD (Foil Only)

588/589

297 X 148 MM
50 GSM PAPER
N/A
N/A
N/A

Component

Unwind Direction (Foil Only)

HM Code

Width (Reel Dimensions) (Foil Only)

CEPHALON
ERYMAX UK
PIL

Product Description

Core (Foil Only)

N/A
N/A

BLACK

Customer Approval
Approved & Proceed

Glue Type (Label Only)

Almac Approval
Amend & Re-submit

Approved & Proceed

Amend & Re-submit

Signed:

Signed:

Print Name:

Print Name:

Shauna McStravick

Date:

Date:

01 Mar 2012

IMPORTANT NOTICE: Please check this artwork for text, spelling, layout, panel orientation, varnish free area, keyline size and position, dimensions, colour
references etc. Whilst we exercise extreme care at all times to ensure accuracy, if you sign this approval you are signifying full approval of design and text. Almac
will not be held responsible for any errors after approval.

For checks that are not required for a particular
component, please detail in the comments section.

0111/17
PX309/12

+ Expand Transcript

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide